##SAMPLE=<ID=NA12878_03,Gender=female,IsTumor=no,IsFFPE=no,DiseaseGroup=n/a,DiseaseStatus=affected>
#chr	start	end	ref	obs	genotype	filter	quality	gene	variant_type	coding_and_splicing	RepeatMasker	dbSNP	1000g	ExAC	ExAC_sub	gnomAD	phyloP	MetaLR	Sift	PP2_HVAR	PP2_HDIV	OMIM	ClinVar	HGMD	COSMIC	GPD_gene	GPD_var	ihdb_hom	ihdb_het	ihdb_wt	ihdb_allsys_hom	ihdb_allsys_het	classification	classification_comment	validated	comment
chr2	215595164	215595164	G	A	het	pred_pathogenic_2	QUAL=334;DP=27;AF=0.44;MQM=60	BARD1	missense,non_coding_exon	BARD1:NM_000465.3:missense:MODERATE:exon10/11:c.1972C>T:p.Arg658Cys,BARD1:NM_001282543.1:missense:MODERATE:exon9/10:c.1915C>T:p.Arg639Cys,BARD1:NM_001282545.1:missense:MODERATE:exon6/7:c.619C>T:p.Arg207Cys,BARD1:NM_001282548.1:missense:MODERATE:exon5/6:c.562C>T:p.Arg188Cys,BARD1:NM_001282549.1:missense:MODERATE:exon4/5:c.433C>T:p.Arg145Cys,BARD1:NR_104212.1:non_coding_exon:MODIFIER:exon9/10:n.1965C>T:,BARD1:NR_104215.1:non_coding_exon:MODIFIER:exon8/9:n.1908C>T:,BARD1:NR_104216.1:non_coding_exon:MODIFIER:exon9/10:n.1164C>T:		rs3738888	0.0054	0.0079	0.0079,0.0123	0.0078	5.1650	T	D,D,D,D	P,D	B,B	601593 [BARD1 (confirmed) Breast cancer,susceptibility to];	RCV000130975.3 [benign]; 	CM067650 [CLASS=DP MUT=ALT PHEN="Lung cancer susceptibility to association with" GENE=BARD1]; 	COSM3782110, COSM3782109	1919		0	0	1	0	12			n/a (1xTP, 0xFP)	
chr2	220422686	220422686	C	T	het	pred_pathogenic_2	QUAL=700;DP=62;AF=0.44;MQM=60	OBSL1	missense,downstream_gene	OBSL1:NM_015311.2:missense:MODERATE:exon11/21:c.3649G>A:p.Glu1217Lys,OBSL1:NM_001173431.1:missense:MODERATE:exon11/14:c.3649G>A:p.Glu1217Lys,OBSL1:NM_001173408.1:downstream_gene:MODIFIER::c.*3392G>A:		rs72957510	0.007	0.0055	0.0234,0.0055	0.0055	0.5010	T	T,D,T,T	P,B,D,B	P,B,P,B	610991 [OBSL1 (confirmed) 3-M syndrome 2];	RCV000174131.1 [benign]; 			18539		0	0.0396	0.9604	2	26				
chr3	142188337	142188337	A	C	het	pred_pathogenic_1	QUAL=11942;DP=680;AF=0.56;MQM=60	ATR	missense	ATR:NM_001184.3:missense:MODERATE:exon38/47:c.6394T>G:p.Tyr2132Asp		rs28910273	0.002	0.0033	0.0033	0.0069	2.3460	T	T,D	B	B	601215 [ATR (confirmed) Seckel syndrome 1|Cutaneous telangiectasia and cancer syndrome,familial];	RCV000145327.1 [uncertain significance]; 			1774		0	0	1	0	17				
chr5	131925483	131925483	G	C	het		QUAL=1006;DP=67;AF=0.49;MQM=60	RAD50	missense	RAD50:NM_005732.3:missense:MODERATE:exon9/25:c.1406G>C:p.Gly469Ala		rs55653181	0.0002	0.0001	0.0001	0	6.3310	T	T,T,T	P	B	604040 [RAD50 (provisional) Nijmegen breakage syndrome-like disorder];				22149		0	0	1	0	0				
chr7	6037057	6037057	-	A	het		QUAL=285;DP=23;AF=0.48;MQM=60	PMS2	splice_region&intron	PMS2:NM_000535.5:splice_region&intron:LOW:exon6/14:c.706-4_706-3insT:,PMS2:NR_003085.2:splice_region&intron:LOW:exon6/14:n.788-4_788-3insT:		rs570998668	0	0	0	0						600259 [PMS2 (confirmed) Mismatch repair cancer syndrome|Colorectal cancer,hereditary nonpolyposis,type 4];	RCV000179768.1 [benign]; 		COSM1735804	20856		0	0.1485	0.8515	0	145				
chr9	21971137	21971137	T	G	het	pred_pathogenic_4	QUAL=404;DP=50;AF=0.46;MQM=60	CDKN2A,C9orf53	missense,synonymous,3'UTR,downstream_gene	CDKN2A:NM_001195132.1:missense:MODERATE:exon2/4:c.221A>C:p.Asp74Ala,CDKN2A:NM_000077.4:missense:MODERATE:exon2/3:c.221A>C:p.Asp74Ala,CDKN2A:NM_058195.3:synonymous:LOW:exon2/3:c.264A>C:p.Arg88Arg,CDKN2A:NM_058197.4:3'UTR:MODIFIER:exon2/3:c.*144A>C:,C9orf53:NR_024274.1:downstream_gene:MODIFIER::n.*616T>G:		rs200429615	0	0.0011	0.0011	0	5.3730	D	D,D	D	D	156540 [MTAP (confirmed) Diaphyseal medullary stenosis with malignant fibrous histiocytoma]:600160 [CDKN2A (confirmed) Melanoma,cutaneous malignant,2|Melanoma and neural system tumor syndrome|Pancreatic cancer/melanoma syndrome|Orolaryngeal cancer,multiple,];			COSM4163711, COSM4163712, COSM4163709, COSM4163710			0	0.3267	0.6733	7	327	1	[1] old entry - no details available		
chr9	98232224	98232224	A	-	het		QUAL=705;DP=57;AF=0.53;MQM=60	PTCH1,LOC100507346	splice_region&intron,non_coding_exon	PTCH1:NM_000264.3:splice_region&intron:LOW:exon12/23:c.1729-11delT:,PTCH1:NM_001083607.1:splice_region&intron:LOW:exon12/23:c.1276-11delT:,PTCH1:NM_001083606.1:splice_region&intron:LOW:exon12/23:c.1276-11delT:,PTCH1:NM_001083604.1:splice_region&intron:LOW:exon12/23:c.1276-11delT:,PTCH1:NM_001083605.1:splice_region&intron:LOW:exon12/23:c.1276-11delT:,PTCH1:NM_001083602.1:splice_region&intron:LOW:exon12/23:c.1531-11delT:,PTCH1:NM_001083603.1:splice_region&intron:LOW:exon12/23:c.1726-11delT:,LOC100507346:NR_038982.1:non_coding_exon:MODIFIER:exon4/4:n.1887delA:			0	0.0014	0.0014	0.0018						601309 [PTCH1 (confirmed) Basal cell nevus syndrome|Basal cell carcinoma,somatic|Holoprosencephaly-7];						0	0	1	0	3				
chr11	94212930	94212930	-	A	het		QUAL=410;DP=514;AF=0.11;MQM=60	MRE11A	splice_region&intron	MRE11A:NM_005591.3:splice_region&intron:LOW:exon4/19:c.315-4_315-3insT:,MRE11A:NM_005590.3:splice_region&intron:LOW:exon4/18:c.315-4_315-3insT:		rs71036325	0	0	0	0						600814 [MRE11A (provisional) Ataxia-telangiectasia-like disorder];	RCV000162501.1 [likely benign]; 			16579		0	0.1386	0.8614	0	354	1	[1] old entry - no details available		
chr16	3639230	3639230	G	A	het	anno_pathogenic_hgmd	QUAL=1724;DP=109;AF=0.49;MQM=60	SLX4	missense	SLX4:NM_032444.2:missense:MODERATE:exon12/15:c.4409C>T:p.Pro1470Leu		rs72778139	0.0002	0.0001	0.0001	0.0002	0.3390	T	T	P	B	613278 [SLX4 (provisional) Fanconi anemia,complementation group P];		CM136925 [CLASS=DM MUT=ALT PHEN="Breast and/or ovarian cancer" GENE=SLX4]; 		27372		0	0	1	0	1				
